F2 and hepatocellular carcinoma: In contrast, sex, arterial hypertension, diabetes, alcohol-related advanced chronic liver disease, metabolic dysfunction-associated steatotic liver disease (MASLD)-related advanced chronic liver disease, hepatocellular carcinoma, age, serum sodium, serum creatinine, aspartate aminotransferase (AST), serum albumin, hemoglobin, prothrombin rate, HVPG, mean arterial pressure, cardiac index, and MELD score were not associated.